Buttgereit F, Dejaco C, Matteson EL, Dasgupta B. Polymyalgia rheumatica and giant cell arteritis: A systematic review. JAMA. 2016;315(22):2442–58.

CAS  PubMed  Google Scholar 

Michet CJ, Matteson EL, Polymyalgia rheumatica. BMJ. 2008;336(7647):765–9.

Sharma A, Mohammad AJ, Turesson C. Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: A systematic literature review. Semin Arthritis Rheum. 2020;50(5):1040–8.

PubMed  Google Scholar 

Dejaco C, Duftner C, Buttgereit F, Matteson EL, Dasgupta B. The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease. Rheumatology (Oxford). 2017;56(4):506–15.

CAS  PubMed  Google Scholar 

Nielsen AW, Frolund LL, Vaben C, Bonde AR, Gormsen LC, de Thurah AL, et al. Concurrent baseline diagnosis of giant cell arteritis and polymyalgia rheumatica - A systematic review and meta-analysis. Semin Arthritis Rheum. 2022;56:152069.

PubMed  Google Scholar 

Floris A, Piga M, Chessa E, Congia M, Erre GL, Angioni MM, et al. Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis. Clin Rheumatol. 2022;41(1):19–31.

PubMed  Google Scholar 

Partington R, Muller S, Mallen CD, Abdul Sultan A, Helliwell T. Comorbidities in patients with polymyalgia rheumatica prior to and following diagnosis: a case control and cohort study. Semin Arthritis Rheum. 2020;50(4):663–72.

CAS  PubMed  Google Scholar 

Gran JT, Myklebust G, Wilsgaard T, Jacobsen BK. Survival in polymyalgia rheumatica and Temporal arteritis: a study of 398 cases and matched population controls. Rheumatology (Oxford). 2001;40(11):1238–42.

CAS  PubMed  Google Scholar 

Doran MF, Crowson CS, O’Fallon WM, Hunder GG, Gabriel SE. Trends in the incidence of polymyalgia rheumatica over a 30 year period in olmsted county, minnesota, USA. J Rheumatol. 2002;29(8):1694–7.

PubMed  Google Scholar 

Raheel S, Shbeeb I, Crowson CS, Matteson EL. Epidemiology of polymyalgia rheumatica 2000–2014 and examination of incidence and survival trends over 45 years: A Population-Based study. Arthritis Care Res (Hoboken). 2017;69(8):1282–5.

PubMed  Google Scholar 

Partington R, Muller S, Mallen CD, Abdul Sultan A, Helliwell T. Mortality among patients with polymyalgia rheumatica: A retrospective cohort study. Arthritis Care Res (Hoboken). 2020.

Gran JT, Myklebust G. The incidence of polymyalgia rheumatica and Temporal arteritis in the County of Aust agder, South norway: a prospective study 1987-94. J Rheumatol. 1997;24(9):1739–43.

CAS  PubMed  Google Scholar 

Myklebust G, Gran JT. A prospective study of 287 patients with polymyalgia rheumatica and Temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. Br J Rheumatol. 1996;35(11):1161–8.

CAS  PubMed  Google Scholar 

Gran JT, Myklebust G. The incidence and clinical characteristics of peripheral arthritis in polymyalgia rheumatica and Temporal arteritis: a prospective study of 231 cases. Rheumatology (Oxford). 2000;39(3):283–7.

CAS  PubMed  Google Scholar 

Myklebust G, Wilsgaard T, Jacobsen BK, Gran JT. Causes of death in polymyalgia rheumatica. A prospective longitudinal study of 315 cases and matched population controls. Scand J Rheumatol. 2003;32(1):38–41.

PubMed  Google Scholar 

Bird HA, Esselinckx W, Dixon AS, Mowat AG, Wood PH. An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis. 1979;38(5):434–9.

CAS  PubMed  PubMed Central  Google Scholar 

Myklebust G, Gran JT. Prednisolone maintenance dose in relation to starting dose in the treatment of polymyalgia rheumatica and Temporal arteritis. A prospective two-year study in 273 patients. Scand J Rheumatol. 2001;30(5):260–7.

CAS  PubMed  Google Scholar 

Salvarani C, Gabriel SE, O’Fallon WM, Hunder GG. Epidemiology of polymyalgia rheumatica in olmsted county, minnesota, 1970–1991. Arthritis Rheum. 1995;38(3):369–73.

CAS  PubMed  Google Scholar 

Schaufelberger C, Bengtsson BA, Andersson R. Epidemiology and mortality in 220 patients with polymyalgia rheumatica. Br J Rheumatol. 1995;34(3):261–4.

CAS  PubMed  Google Scholar 

Hill CL, Black RJ, Nossent JC, Ruediger C, Nguyen L, Ninan JV, et al. Risk of mortality in patients with giant cell arteritis: A systematic review and meta-analysis. Semin Arthritis Rheum. 2017;46(4):513–9.

PubMed  Google Scholar 

Camellino D, Matteson EL, Buttgereit F, Dejaco C. Monitoring and long-term management of giant cell arteritis and polymyalgia rheumatica. Nat Rev Rheumatol. 2020;16(9):481–95.

CAS  PubMed  Google Scholar 

Kermani TA, Warrington KJ, Crowson CS, Ytterberg SR, Hunder GG, Gabriel SE, et al. Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis. Ann Rheum Dis. 2013;72(12):1989–94.

PubMed  Google Scholar 

Movahedi M, Costello R, Lunt M, Pye SR, Sergeant JC, Dixon WG. Oral glucocorticoid therapy and all-cause and cause-specific mortality in patients with rheumatoid arthritis: a retrospective cohort study. Eur J Epidemiol. 2016;31(10):1045–55.

CAS  PubMed  PubMed Central  Google Scholar 

Einarsdottir MJ, Ekman P, Molin M, Trimpou P, Olsson DS, Johannsson G, et al. High mortality rate in oral glucocorticoid users: A Population-Based matched cohort study. Front Endocrinol (Lausanne). 2022;13:918356.

PubMed  Google Scholar 

Unizony S, Menendez ME, Rastalsky N, Stone JH. Inpatient complications in patients with giant cell arteritis: decreased mortality and increased risk of thromboembolism, delirium and adrenal insufficiency. Rheumatology (Oxford). 2015;54(8):1360–8.

PubMed  Google Scholar 

Garen T, Lerang K, Hoffmann-Vold AM, Andersson H, Midtvedt O, Brunborg C, et al. Mortality and causes of death across the systemic connective tissue diseases and the primary systemic vasculitides. Rheumatology (Oxford). 2019;58(2):313–20.

PubMed  Google Scholar 

Milchert M, Brzosko M. Familial aggregation of longevity in giant cell arteritis and polymyalgia rheumatica. Rheumatol Int. 2020;40(12):2071–5.

CAS  PubMed  PubMed Central  Google Scholar 

Dasgupta B, Cimmino MA, Kremers HM, Schmidt WA, Schirmer M, Salvarani C, et al. 2012 provisional classification criteria for polymyalgia rheumatica: a European league against rheumatism/american college of rheumatology collaborative initiative. Arthritis Rheum. 2012;64(4):943–54.

PubMed  Google Scholar 

Macchioni P, Boiardi L, Catanoso M, Pazzola G, Salvarani C. Performance of the new 2012 EULAR/ACR classification criteria for polymyalgia rheumatica: comparison with the previous criteria in a single-centre study. Ann Rheum Dis. 2014;73(6):1190–3.

PubMed  Google Scholar 

Ozen G, Inanc N, Unal AU, Bas S, Kimyon G, Kisacik B, et al. Assessment of the new 2012 EULAR/ACR clinical classification criteria for polymyalgia rheumatica: A prospective multicenter study. J Rheumatol. 2016;43(5):893–900.

PubMed  Google Scholar 

Chuang TY, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med. 1982;97(5):672–80.

CAS  PubMed  Google Scholar 

Salvarani C, Cantini F, Macchioni P, Olivieri I, Niccoli L, Padula A, et al. Distal musculoskeletal manifestations in polymyalgia rheumatica: a prospective followup study. Arthritis Rheum. 1998;41(7):1221–6.

CAS  PubMed  Google Scholar 

Helliwell T, Hider SL, Mallen CD. Polymyalgia rheumatica: diagnosis, prescribing, and monitoring in general practice. Br J Gen Pract. 2013;63(610):e361–6.

PubMed  PubMed Central  Google Scholar 

Myklebust G, Wilsgaard T, Jacobsen BK, Gran JT. No increased frequency of malignant neoplasms in polymyalgia rheumatica and Temporal arteritis. A prospective longitudinal study of 398 cases and matched population controls. J Rheumatol. 2002;29(10):2143–7.

PubMed  Google Scholar 

Huo RX, Yang YT, Lin JY, Meng DL, Huang RJ, Huo XC, et al. Mortality associated with polymyalgia rheumatica in the united States in the 1999–2020 period: a multiple-cause-of-death study. Eur Rev Med Pharmacol Sci. 2024;28(8):3144–53.

PubMed  Google Scholar